Churg-Strauss Syndrome clinical trials at UCSD
1 research study open to eligible people
open to all eligible people
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.
San Diego, California and other locations
Our lead scientists for Churg-Strauss Syndrome research studies include Praveen Akuthota, MD.